Key building blocks for the production of fully synthetic macrolides have been scaled-up in first time pilot plant and kilo-lab campaigns. These building blocks have supported the discovery of new macrolide antibiotics as well as ongoing preclinical studies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/ja.2017.116 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!